EQRx to Participate in the Jefferies 2022 London Healthcare Conference
CAMBRIDGE, Mass., Nov. 07, 2022 (GLOBE NEWSWIRE) — EQRx, Inc. (Nasdaq:EQRX), a new type of pharmaceutical company committed to developing and delivering innovative medicines to patients at substantially lower prices, today announced that management will participate in a fireside chat at the Jefferies 2022 London Healthcare Conference on Thursday, November 17, 2022, at 1:30 p.m. GMT / 8:30 a.m. EST.
Related news for (EQRX)
- EQRX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of EQRx, Inc. – EQRX
- EQRX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of EQRx, Inc. – EQRX
- EQRx to Hold First Quarter 2023 Financial Results Conference Call on Monday, May 8, 2023
- EQRx to Hold First Quarter 2023 Financial Results Conference Call on Monday, May 8, 2023
- EQRx to Present at the 41st Annual J.P. Morgan Healthcare Conference